The Story Of Our Firm | En Español
 Home    Lawyers   Litigation   Choose Us   Settlements   Search
FONT SIZE: A A A A A

Previous Investigations Other Litigations Guidant Defibrillator Research Center

MADIT II and SCD-HEFT Comment

in this section: Recall | FDA Pacemaker Recall | Breaking News | Guidant Corporation Press Release | St. Jude Medical, Inc. Press Release | Nonischemic Dilated Cardiomyopathy Comment | MADIT II and SCD-HEFT Comment | Current Medicare Criteria Comment | April 2007 Recall--'Doctor's Letter' | Guidant Settlement Talks, 5.16.07 | FDA Q&A on 4/07 Recall | Settlement News, 7.20.07

Bookmark This Page Print This Page Email This Page

Initial Public Comments Implantable Cardiac Defibrillators

BREAKING NEWS: 10.15.07--Medtronic, Inc., the world's largest maker of electronic heart devices, announced they are suspending sales of Sprint Fidelis leads. According to the FDA, these wires, used to connect defibrillators to the heart, may break or erode and may increase chance of injury. Learn more about the Medtronic Sprint Fidelis Recall.

Comment Four
May 25-June 25, 2004
Comment #4:
Name: Kousik Krishnan, MD, FACC
Organization: Rush University Medical Center
Date: Fri, June 25, 2004

As a board certified cardiac, I feel that I have a responsibility as a patient advocate to express my thoughts on the matter. I will be brief. I believe that the MADIT II results along with the soon to be published SCD- HEFT Results offer compelling, if not overwhelming evidence that ICD's improve mortality in both ischemic and nonischemic cardiomyopathies. The data does not support arbitrary sub-group analysis to restrict their use. While the date may be even more compelling in patients with a QRS duration greater than 120 ms, this does not negate the fact that all patient groups showed a marked improvement in mortality.

I feel that morally we cannot restrict this technology.

I urge a full reevaluation and approval for the whole MADIT II and SCD-HEFT populations.

Have you been injured by a Guidant Defibrillator? An experienced attorney can help protect you. Fill out the simple form below to contact an experienced defibrillator lawyer before your time limit to file suit runs out.

 

Weitz & Luxenberg is no longer accepting Guidant Defibrillator cases.


see also:

MADIT II and SCD-HEFT Comment Guidant Defibrillators Initial Public Comments 4
Initial Public Comments on Guidant's Implantable Cardiac Defibrillator

Recall Guidant Defibrillator: Learn the dangers and how a lawsuit can help
Learn more about the Guidant Defibrillator lawsuit

News & Warnings Guidant Defibrillator - Public Commentary on Defibrillators and the Guidant Recall
Guidant defibrillator recall public comment. FREE lawsuit information
Free Legal Review
Name:
Phone:
Email:
Case Description:
$53 million verdict — brake mechanic suffering from mesothelioma

$13.5 million verdict — one of the very first Vioxx trial cases

$15 million settlement — man wound up a paraplegic due to negligent hospital care

$37 million verdict — 2 asbestos lung cancer plaintiffs

$47 million verdict — boilermaker who died from mesothelioma

$2.6 million settlement — ill-fitting prosthesis caused decubitus ulcers

$75 million verdict — historic consolidated trial involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s

$12.7 million verdict — iron worker who was injured due to unsafe working conditions

$8 million settlement — obstetrical malpractice resulted in neurological deficits

$64.65 million award — 4 asbestos plaintiffs

$17.5 million — consolidated trial of 5 mesothelioma victims


Ask a Free Question:
Were you injured?

check for your response [login]
For legal help anywhere in the U.S.
A nationally-recognized personal injury law firm, Weitz & Luxenberg is committed to helping clients win cases, get the compensation to which they’re entitled and continue with their lives. In just over 20 years, we’ve collected more than $1.3 billion for plaintiffs.